GastroKarger Profile Banner
Gastroenterology | Karger Profile
Gastroenterology | Karger

@GastroKarger

Followers
3K
Following
158
Media
790
Statuses
867

@KargerPublisher is a globally active publishing house in Health Sciences. Gastroenterology is a main field of expertise of Karger. #GastroKarger

Basel, Switzerland
Joined April 2020
Don't wanna be here? Send us removal request.
@GastroKarger
Gastroenterology | Karger
11 months
Discover the most impactful articles in #Gastroenterology 🧵 ⬇️
Tweet media one
1
0
0
@GastroKarger
Gastroenterology | Karger
2 months
📚Explore the "#ArtificialIntelligence in #Gastroenterology" Article Collection!. This collection highlights AI-driven advances in GI diagnostics, cancer detection, liver imaging & personalized care. 🔗Stay informed:
Tweet media one
0
1
1
@grok
Grok
3 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
1K
3K
11K
@GastroKarger
Gastroenterology | Karger
3 months
RT @KargerPublisher: Are you an early-stage #startup driving innovation in #SciComm? The #VesaliusInnovationAward is here to recognize and….
0
7
0
@GastroKarger
Gastroenterology | Karger
4 months
📢 Call for Papers in #Digestion for "Functional Diseases” .📅 Submission Deadline: November 30, 2025.🔬 Contribute your research to our article collection!. 🔗 @KargerPublisher
Tweet media one
0
1
1
@GastroKarger
Gastroenterology | Karger
4 months
📢 Call for Papers in #Digestion for "Controversial Issues in Gastroenterology” .📅 Submission Deadline: October 31, 2025.🔬 Contribute your research to our article collection!. 🔗 @KargerPublisher
Tweet media one
0
1
1
@GastroKarger
Gastroenterology | Karger
5 months
RT @KargerPublisher: For 2025, three journals- Developmental Neuroscience, European Addiction Research, and Neurodegenerative Diseases- hav….
0
7
0
@GastroKarger
Gastroenterology | Karger
5 months
🚀 Introducing Karger #Researcher Communities! 🚀. Your go-to hub for navigating the #publishing journey with confidence. Get expert insights, tailored resources, and recognition for your contributions to #science. Join now 🔗
Tweet media one
0
0
0
@GastroKarger
Gastroenterology | Karger
6 months
📢 Call for Papers in #Digestion for "Current Management of Duodenal Neoplasia” .📅 Extended Deadline: March 31, 2025.🔬 Contribute your research to our article collection!.🔗 @KargerPublisher
Tweet media one
0
1
1
@GastroKarger
Gastroenterology | Karger
7 months
📊 Struggling to find the perfect visuals for your #research? . Introducing Karger Image Explorer, containing over 260,000+ peer-reviewed images for reuse in your research, publications and teaching. Start image search 🔗
Tweet media one
0
0
1
@GastroKarger
Gastroenterology | Karger
7 months
@KargerPublisher
Karger Publishers
7 months
2024 has been a remarkable journey for Karger!. Thank you to our incredible #KargerTeam and loyal customers for making last year unforgettable. Here’s to even greater heights in 2025! 🚀. Get a glimpse of our 2024 #highlights ✨. #YearInReview #CompanyHighlights #2024Recap
0
0
1
@GastroKarger
Gastroenterology | Karger
7 months
RT @KargerPublisher: Our popular series #KargerInConversation is back!. Join us on February 6 for a dynamic panel discussion exploring how….
0
2
0
@GastroKarger
Gastroenterology | Karger
8 months
Alteration of the Gut #Microbiome in #Inflammatory Bowel Disease.🔗 ✍ Andoh A. et al. 📖 #Digestion
Tweet media one
0
2
1
@GastroKarger
Gastroenterology | Karger
8 months
Wishing you a joyous holiday season and a happy New Year! ✨. #SeasonsGreetings
Tweet media one
0
0
0
@GastroKarger
Gastroenterology | Karger
8 months
Is Total #Neoadjuvant Treatment Beneficial for Locally Advanced Rectal #Cancer? A Meta-Analysis of Randomized Controlled Trials .🔗 ✍ Wu H. et al. 📖 #Oncology
Tweet media one
0
0
0
@GastroKarger
Gastroenterology | Karger
8 months
RT @Science_Open: 'Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal….
scienceopen.com
Introduction: CT-guided interstitial brachytherapy (iBT) radiotherapy has been established in the treatment of liver tumors. With iBT, hepatocellular carcinoma (HCC) lesions can be treated beyond the...
0
1
0
@GastroKarger
Gastroenterology | Karger
8 months
RT @Science_Open: 'Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carci….
scienceopen.com
Introduction: Patients with liver cirrhosis develop thrombocytopenia and an increased risk of bleeding events after invasive procedures. Lusutrombopag, a thrombopoietin receptor agonist, can increase...
0
1
0
@GastroKarger
Gastroenterology | Karger
8 months
Referral for #Dietary Intervention in Celiac #Disease Is Low among #Gastroenterologists and Primary Care Providers.🔗 ✍ Venkateswaran N. et al. 📖 #DigDis
Tweet media one
0
0
0
@GastroKarger
Gastroenterology | Karger
8 months
#Thyroid Dysfunction after #Atezolizumab and #Bevacizumab Is Associated with Favorable Outcomes in #Hepatocellular Carcinoma.🔗 ✍ Song Y. et al. 📖 #LiverCancer
Tweet media one
0
0
0